The latest findings include RNA-sequencing data showing that GRI-0621 significantly modulated genes associated with lung ...

Short-sellers have been ramping up their positions in both Editas Medicine and Bluebird Bio lately. With multiple options on the table, Editas and Bluebird could both blaze the comeback trail. Editas ...

WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, today issued a ...

IBRX has a short interest % of the float of 33%, superior to GME at 21%. Investors should keep an eye on it for short squeeze-fueled volatility. IBRX has positive catalysts on the horizon, such as the ...

bluebird bio reported a net income of $21.2 million in Q1 2023, a significant turnaround from a net loss of $122.2 million in the same period in 2022, primarily due to a one-time gain from the sale of ...

If you’re a candidate for C-suite, Partner, or Board roles, you’ll be asked for a bio as part of the process. For some roles reporting to the C-suite, you may need a bio as well. Employers evaluating ...

On Wednesday, shares of bluebird bio, Inc. BLUE experienced volatile short activity. After the activity, the stock price went down -10.06% to $6.17. The overall sentiment for BLUE has been Bearish.

Short interest in Generation Bio Co (NASDAQ:GBIO) decreased during the last reporting period, falling from 1.69M to 1.67M. This put 3.64% of the company's publicly available shares short. Short ...

In case you've faced some hurdles solving the clue, Tribute with a short bio, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and ...